Sontra Medical Corporation raised a round of funding worth $1M. Sontra is an OTC company that has raised this amount via a Private Placement. The early stage development company is creating transdermal glucose monitor ("CTGM") for use in the Diabetes and Intensive Care Markets.
Sontra Medical Profile
Abonohu te:
Posto komente (Atom)
Nuk ka komente:
Posto një koment